CORT vs. HIMS
CORT (Corcept Therapeutics Incorporated) and HIMS (Hims & Hers Health, Inc.) are both stocks. Both are in the Healthcare sector — CORT in Biotechnology, HIMS in Drug Manufacturers - Specialty & Generic. Over the past 5 years, CORT returned 30.95%/yr vs 17.04%/yr for HIMS. At a 0.27 correlation, their price movements are largely independent.
Performance
CORT vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CORT achieves a 138.25% return, which is significantly higher than HIMS's -17.40% return.
CORT
- 1D
- -0.41%
- 1M
- 45.25%
- YTD
- 138.25%
- 6M
- -5.77%
- 1Y
- 16.48%
- 3Y*
- 52.65%
- 5Y*
- 30.95%
- 10Y*
- 31.68%
HIMS
- 1D
- -7.10%
- 1M
- 11.10%
- YTD
- -17.40%
- 6M
- -27.92%
- 1Y
- -53.07%
- 3Y*
- 43.69%
- 5Y*
- 17.04%
- 10Y*
- —
CORT vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 138.25% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.50% |
HIMS Hims & Hers Health, Inc. | -17.40% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
Correlation
The correlation between CORT and HIMS is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.27 |
Fundamentals
CORT:
$8.66B
HIMS:
$6.12B
CORT:
$0.41
HIMS:
-$0.05
CORT:
12.51
HIMS:
2.78
CORT:
13.57
HIMS:
13.73
CORT:
$769.10M
HIMS:
$2.37B
CORT:
$755.64M
HIMS:
$1.70B
CORT:
$3.66M
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CORT vs. HIMS — Risk / Return Rank
CORT
HIMS
CORT vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CORT | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.77 | ||
| Sortino ratioReturn per unit of downside risk | +1.27 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 0.95 | +0.23 |
| Calmar ratioReturn relative to maximum drawdown | 0.26 | -0.68 | +0.94 |
| Martin ratioReturn relative to average drawdown | 0.47 | -1.10 | +1.57 |
Loading charts...
Drawdowns
CORT vs. HIMS - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.29%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for CORT and HIMS.
Loading charts...
Drawdown Indicators
| CORT | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.29% | -87.29% | -7.00% |
Max Drawdown (1Y)Largest decline over 1 year | -64.40% | -78.06% | +13.66% |
Max Drawdown (3Y)Largest decline over 3 years | -71.85% | -78.88% | +7.03% |
Max Drawdown (5Y)Largest decline over 5 years | -71.85% | -78.88% | +7.03% |
Max Drawdown (10Y)Largest decline over 10 years | -71.85% | — | — |
Current DrawdownCurrent decline from peak | -27.41% | -60.98% | +33.57% |
Average DrawdownAverage peak-to-trough decline | -53.45% | -43.23% | -10.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.37% | 48.06% | -12.69% |
Volatility
CORT vs. HIMS - Volatility Comparison
The current volatility for Corcept Therapeutics Incorporated (CORT) is 14.28%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 21.36%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CORT | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.28% | 21.36% | -7.08% |
Volatility (6M)Calculated over the trailing 6-month period | 85.36% | 67.20% | +18.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 76.98% | 96.46% | -19.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.58% | 83.26% | -8.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.23% | 77.20% | -9.97% |
Dividends
CORT vs. HIMS - Dividend Comparison
Neither CORT nor HIMS has paid dividends to shareholders.
Financials
CORT vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CORT vs. HIMS - Profitability Comparison
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
Frequently Asked Questions
CORT and HIMS have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (21.36%) compared to CORT (14.28%). In terms of maximum drawdown, CORT dropped -94.29% vs HIMS's -87.29%.
CORT currently has the higher Sharpe Ratio (0.21 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CORT and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer